Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
Patients’ perception of their illness and coping styles may play a role in whether hand osteoarthritis pain improves or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback